| Financial Year |
March 31 2023 |
| Monetary Funds |
815,345,626.28 |
| Held-for-trading Financial Assets |
216,006,520.00 |
| Notes Receivable |
128,394,709.42 |
| Accounts Receivable |
1,478,980,287.13 |
| Advances to Suppliers |
189,776,197.70 |
| Other Receivables |
166,860,879.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
903,364,793.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,004,600.00 |
| Other Current Assets |
224,728,843.67 |
| Total Current Assets |
5,200,959,198.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,391,700.00 |
| Long-term Equity Investment |
441,062,111.90 |
| Investment Properties |
-- |
| Fixed Assetes |
700,555,516.19 |
| Under-construction Projects |
380,445,570.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,068,811,779.21 |
| R&D expenses |
-- |
| Goodwill |
800,394,388.81 |
| Long-Term Deferred and Prepaid Expenses |
21,479,467.10 |
| Deferred Income Tax Assets |
121,028,626.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,601,109,868.55 |
| Total Assets |
9,802,069,066.60 |
| Short-Term Loans |
1,473,941,826.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
416,986,124.64 |
| Accounts Payable |
1,007,589,243.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,865,119.13 |
| Taxes Payable |
121,871,883.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,053,619.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
69,613,938.07 |
| Other Current Liabilities |
125,320,552.86 |
| Sub-Total of Current Liabilities |
3,631,545,250.12 |
| Long-term Loans |
976,594,366.90 |
| Bonds Payable |
856,451,898.59 |
| Long-Term Accounts Payable |
150,048,905.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
36,493,902.08 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,222,174,488.00 |
| Total Liabilities |
5,853,719,738.12 |
| Paid-In Capital(Or Share Stock) |
781,588,507.00 |
| Capital Surplus |
2,239,013,978.58 |
| Surplus Reserve |
112,774,095.51 |
| LESS:Treasury Stock |
11,439,815.00 |
| Undistributed Profits |
696,080,308.07 |
| Minority Stockholder's Interest |
127,709,880.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,820,639,448.25 |
| Owner's Equity（Stockholder's Equity） |
3,948,349,328.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,802,069,066.60 |
